4/12/2013

Merck & Co. granted Hawaii Biotech rights to a group of patents involving West Nile virus vaccine technology and a nonexclusive license for associated technologies. The deal will allow Hawaii Biotech to continue work on its West Nile virus vaccine, said CEO Elliot Parks.

Related Summaries